In

Inflammopharmacology

Inflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy. It compares different inflammatory states and their causes, examines the actions, therapeutic efficacy and safety of drugs used in the treatment of inflammatory conditions, and covers Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals, with particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs, as well as the safety and efficacy of non-prescription and prescription NSAIDs and analgesics.

Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Impact Factor 5.3
Quartile Q1
Open Access Type Hybrid
ISSN 0925-4692
eISSN 1568-5608
Invitation Only No
Cost Range Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR; subscription publishing available with no APC.

Submission Instructions

Inflammopharmacology accepts the following article types. Click on an article type to view submission instructions.

Research

Cover Letter An accompanying letter must include a statement that the paper is original, unpublished, and not under consideration elsewhere. The accompanying letter must state that the paper is original, unpublished, and not under consideration elsewhere.
Abstract An abstract is required. Abstract must be 150 to 250 words.
Manuscript Research manuscripts should not exceed 8 printed pages, with approximately 870 words or 4700 characters without spaces per printed page, excluding figures and tables from the page text allowance. Manuscript should include Introduction, Methods & Materials, Results, and Discussion and Conclusions sections. Manuscript must include 4 to 6 keywords, a Data Availability Statement, a disclosure statement, a 'Statements and Declarations' section after the References, and documentation of any large language model use in the Methods section or another suitable section if no Methods section is available.
References References must be cited in the text by name and year in parentheses. Reference list must include only cited published or accepted works, be alphabetized by the last name of the first author, and include full DOI links when available.
Figures & Tables Figures and tables are counted in addition to the printed page text allowance for Research manuscripts. Figure captions must be included in the manuscript text file rather than within the figure files. Figures and tables must be numbered with Arabic numerals and cited in the text in consecutive numerical order, each table must have a caption, and each figure must have a concise caption.
Reformat to Inflammopharmacology using Livewrite Premium

Reviews

Cover Letter An accompanying letter is required. The accompanying letter must state that the paper is original, unpublished, and not under consideration elsewhere.
Abstract An abstract is required. Abstract must be 150 to 250 words.
Manuscript Reviews should not exceed 12 printed pages. Review articles must include a contribution statement identifying who had the idea for the article, who performed the literature search and data analysis, who drafted or critically revised the work, and a disclosure statement, and the manuscript must include 4 to 6 keywords, a 'Statements and Declarations' section after the references with funding and competing interests statements, and documentation of any large language model use in the Methods section or another suitable section if no Methods section is available.
References Citations must use name-and-year style in the text. The reference list must include only works cited in the text that are published or accepted for publication, be alphabetized by the last name of the first author, include full DOI links when available, and use standard journal title abbreviations.
Figures & Tables Figure captions must be included in the manuscript text file rather than in the figure files. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by concise captions, and figure parts must be labeled with lowercase letters.
Reformat to Inflammopharmacology using Livewrite Premium

Brief Report

Cover Letter A cover letter is required. The accompanying letter must state that the paper is original, unpublished, and not under consideration elsewhere.
Abstract An abstract is required. Abstract must be 150 to 250 words.
Manuscript Brief Report submissions should preferably be no more than 2 printed pages long. Brief Report submissions should be complete in themselves, have a short introduction, and combine the results and discussion in one section. Provide 4 to 6 keywords, include documentation of any large language model use in the Methods section or another suitable section when no Methods section is available, and include a 'Statements and Declarations' section after the References section with at least Funding and Competing Interests statements.
References Citations must use name-and-year style in the text. The reference list must include only works cited in the text that have been published or accepted for publication, be alphabetized by the last name of the first author, use standard journal name abbreviations, include full DOI links when available, and remain focused on research details.
Figures & Tables Figure captions must be included in the manuscript text file rather than in the figure files. Figures and tables must be numbered in Arabic numerals, cited in the text in consecutive numerical order, and each must have a concise caption.
Reformat to Inflammopharmacology using Livewrite Premium

Correspondence

Cover Letter An accompanying letter must be submitted with a statement that the paper is original, unpublished, and not under consideration elsewhere. The cover letter must state that the paper is original, unpublished, and not under consideration elsewhere.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include a 'Statements and Declarations' section after the References section and should document any use of a large language model in the Methods section or another suitable section if no Methods section is available.
References References must be cited in the text by name and year in parentheses. The reference list must include only works cited in the text that are published or accepted for publication, be alphabetized by the first author's last name, and include full DOI links when available.
Figures & Tables Figure captions must be included in the manuscript text file rather than within the figure files, and figures must be supplied electronically. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order in the text, and accompanied by concise captions.
Reformat to Inflammopharmacology using Livewrite Premium

Recent Publications

Kaempferol-loaded solid lipid nanoparticles attenuate cartilage degradation and inflammation by modulating the expression of pro and inflammatory cytokines, MMP-13 and oxidative stress markers in adjuvant induced arthritic rats

Anam Niamat, Aftab Ahmad, Nayla Munawar, Muhammad Shahid, Bushra Akhtar

10.1007/s10787-026-02269-4
View Publication

Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies

Francesco Ferrara

10.1007/s10787-026-02273-8
View Publication

Neuroprotective role of cyanidin in Alzheimer’s and Parkinson’s disease: current insights and the road ahead

Bushra Bashir, Nandani Andotra, Prince Sharma, Tripti Sharma, Smriti Chauhan, Ankit Awasthi, Shareen Singh, Thakur Gurjeet Singh, Sachin Kumar Singh, Sukriti Vishwas

10.1007/s10787-026-02271-w
View Publication

RGRN-305, a novel Hsp90 inhibitor: a promising therapeutic option for inflammatory dermatologic diseases

Nazila Heidari, Homayoun Pishraft-Sabet, Rayhaneh Gol, Dorsa Najari, Sara Eghbali, Amirhossein Heidari, Hamidreza Mahmoudi

10.1007/s10787-026-02265-8
View Publication

Nature meets immunity: curcumin’s role in modulating neutrophil extracellular traps

Amirhossein Sahebkar, Elaheh Mirhadi, Tannaz Jamialahmadi, Sercan Karav, Prashant Kesharwani

10.1007/s10787-026-02252-z
View Publication

Frequently asked questions

How long does it take to publish?

All manuscripts are reviewed anonymously by at least two independent reviewers. Articles are published online after receipt of the corrected proofs.

Reformat to Inflammopharmacology using Livewrite Premium

Is a cover letter required?

An accompanying letter submitted with the manuscript should state that the paper is original, unpublished, and not under consideration elsewhere. The corresponding author should mention unpublished material included in the manuscript in a cover letter to the editor.

Reformat to Inflammopharmacology using Livewrite Premium

What are the publication costs?

Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR. Subscription publishing is available with no APC.

Reformat to Inflammopharmacology using Livewrite Premium

Research Topics

Inflammatory mediators and NSAID effects Rheumatoid Arthritis Research and Therapies Pharmacological Effects of Natural Compounds Natural product bioactivities and synthesis Helicobacter pylori-related gastroenterology studies Pain Mechanisms and Treatments Essential Oils and Antimicrobial Activity Neuroinflammation and Neurodegeneration Mechanisms Inflammasome and immune disorders Inflammatory Bowel Disease Osteoarthritis Treatment and Mechanisms Phytochemistry and Biological Activities Curcumin's Biomedical Applications COVID-19 Clinical Research Studies Immune Response and Inflammation Neuropeptides and Animal Physiology Tryptophan and brain disorders Pharmacological Effects of Medicinal Plants Alzheimer's disease research and treatments Eicosanoids and Hypertension Pharmacology NF-κB Signaling Pathways Phytochemicals and Antioxidant Activities Genomics, phytochemicals, and oxidative stress Drug-Induced Hepatotoxicity and Protection Psoriasis: Treatment and Pathogenesis